Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design

Annelienke M. van Hulst; Martha A. Grootenhuis; Erica L.T. van den Akker; Marry M. van den Heuvel-Eibrink

doi:10.1016/j.ejca.2023.112980

Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design

Annelienke M. van Hulst^*, Martha A. Grootenhuis, Erica L.T. van den Akker, Marry M. van den Heuvel-Eibrink

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	112980
Number of pages	1
Journal	European journal of cancer (Oxford, England : 1990)
Volume	191
DOIs	https://doi.org/10.1016/j.ejca.2023.112980
Publication status	Published - 1 Sept 2023

Bibliographical note

Funding Information:
No acknowledgements to report.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2023.112980

Cite this

van Hulst, A. M., Grootenhuis, M. A., van den Akker, E. L. T., & van den Heuvel-Eibrink, M. M. (2023). Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design. European journal of cancer (Oxford, England : 1990), 191, Article 112980. https://doi.org/10.1016/j.ejca.2023.112980

van Hulst, Annelienke M. ; Grootenhuis, Martha A. ; van den Akker, Erica L.T. et al. / Response to letter entitled : Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design. In: European journal of cancer (Oxford, England : 1990). 2023 ; Vol. 191.

@article{46d78e77e7164dcf9bd29368d8256cb1,

title = "Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design",

author = "{van Hulst}, {Annelienke M.} and Grootenhuis, {Martha A.} and {van den Akker}, {Erica L.T.} and {van den Heuvel-Eibrink}, {Marry M.}",

note = "Funding Information: No acknowledgements to report.",

year = "2023",

month = sep,

day = "1",

doi = "10.1016/j.ejca.2023.112980",

language = "English",

volume = "191",

journal = "European journal of cancer (Oxford, England : 1990)",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

van Hulst, AM, Grootenhuis, MA, van den Akker, ELT & van den Heuvel-Eibrink, MM 2023, 'Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design', European journal of cancer (Oxford, England : 1990), vol. 191, 112980. https://doi.org/10.1016/j.ejca.2023.112980

Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design. / van Hulst, Annelienke M.; Grootenhuis, Martha A.; van den Akker, Erica L.T. et al.
In: European journal of cancer (Oxford, England : 1990), Vol. 191, 112980, 01.09.2023.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Response to letter entitled

T2 - Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design

AU - van Hulst, Annelienke M.

AU - Grootenhuis, Martha A.

AU - van den Akker, Erica L.T.

AU - van den Heuvel-Eibrink, Marry M.

N1 - Funding Information: No acknowledgements to report.

PY - 2023/9/1

Y1 - 2023/9/1

UR - http://www.scopus.com/inward/record.url?scp=85168808132&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2023.112980

DO - 10.1016/j.ejca.2023.112980

M3 - Comment/Letter to the editor

C2 - 37574396

AN - SCOPUS:85168808132

SN - 0959-8049

VL - 191

JO - European journal of cancer (Oxford, England : 1990)

JF - European journal of cancer (Oxford, England : 1990)

M1 - 112980

ER -

van Hulst AM, Grootenhuis MA, van den Akker ELT, van den Heuvel-Eibrink MM. Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design. European journal of cancer (Oxford, England : 1990). 2023 Sept 1;191:112980. doi: 10.1016/j.ejca.2023.112980

Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this